Watchlist Price Alert

Cidara Therapeutics Inc. (CDTX)

NASDAQ: CDTX · Real-Time Price · USD

21.95

-0.46 (-2.05%)

At close: Jun 17, 2025, 12:30 PM

Cidara Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-169.83M	-22.93M	-29.8M	-42.47M	-72.11M	-41.09M	-59.02M	-55.73M	-48.16M
Depreciation & Amortization	233K	118K	1.23M	-1.23M	229K	375K	523K	667K	732K
Stock-Based Compensation	3.91M	3.06M	3.53M	4.01M	4.09M	5.07M	5.71M	5.71M	4.34M
Other Working Capital	-33.3M	3.7M	-584K	8.62M	24.52M	8.27M	-340K	-1.22M	1.57M
Other Non-Cash Items	3.09M	1.24M	1K	15K	21K	36K	86K	50K	14K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	-411K	-3.61M	-33K	-176K
Change in Working Capital	-13.93M	-3.92M	-3.43M	14.44M	13.36M	7.49M	-399K	-579K	3.48M
Operating Cash Flow	-176.53M	-22.43M	-28.47M	-25.23M	-54.41M	-28.53M	-56.7M	-49.91M	-39.77M
Capital Expenditures	-129K	-505K	-118K	-41K	-186K	-35K	-177K	-306K	-401K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	-14.55M	-19.52M	-69.62M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	29.03M	24.3M	95.5M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	14.48M	4.78M	25.88M
Investing Cash Flow	-129K	-505K	-118K	-41K	-186K	-35K	14.3M	4.47M	25.48M
Debt Repayment	-276K	n/a	-2.59M	-4.44M	-2.96M	n/a	n/a	n/a	9.95M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-79K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-39K	21K	-720K	6K	14K	-24K	49.71M	228K	525K
Financial Cash Flow	337.06M	25.98M	-951K	44.6M	37.28M	14.27M	56.15M	20.88M	37.09M
Net Cash Flow	160.4M	3.05M	-29.54M	19.32M	-17.32M	-14.29M	13.75M	-24.55M	22.8M
Free Cash Flow	-176.66M	-22.94M	-28.59M	-25.27M	-54.6M	-28.57M	-56.88M	-50.22M	-40.17M